…
Our experts discuss which companies to buy, sell or hold this week…
Donald Trump zwingt Pharmakonzerne zu Preisnachlässen. Doch ausgerechnet Johnson & Johnson liefert überraschend starke Zahlen. Anleger stellen sich nun eine…
In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $239.63, denoting a -2.31% move from…
Johnson & Johnson has launched a website to sell some of its drugs directly to U.S. patients who either dont…
Johnson & Johnson launches website for direct-to-consumer sales…
Image source: The Motley Fool.DATETuesday, March 3, 2026 at 5 p.m. ETCALL PARTICIPANTSChief Executive Officer — Jerrell SheltonChief Financial Officer…
Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:Jason Gerberry, Analyst von BofA Securities, stuft die Aktie von Johnson &…
Transcript: Caroline WoodsBig tech has dominated portfolios for years, but David Johnsons top stock picks right now dont include a…
Johnson Service Group (LON: JSG) has shown its ability to grow despite the weak consumer market hitting its core customer…
Johnson & Johnson (JNJ) closed the most recent trading day at $248.43, moving +2.04% from the previous trading session.…
RACINE, Wis., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…
Image source: The Motley Fool.DATEThursday, Feb. 26, 2026 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Daniel T.…
BLD expands in Texas with the Johnson Roofing buy, boosting its commercial roofing platform and regional scale as shares edge…
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Image source: The Motley Fool.DateFeb. 25, 202610 a.m. ETCall participantsPresident & Chief Executive Officer — Jennifer L. ShermanVice President &…
Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…
Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…
DAYTONA BEACH, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer of insulation and…
Von Nicholas G. Miller DOW JONES--Die Bayer AG verklagt Johnson Johnson (JJ) und deren Sparte Janssen Biotech wegen…
By David Bautz, PhDNASDAQ:CYCNREAD THE FULL CYCN RESEARCH REPORTBusiness UpdatePositive Regulatory Feedback Supports Phase 2 Trial Initiation in 2H26On February…
JNJs diversified model, $32B R&D push and 48% stock surge in a year raise the stakes in its battle with…
Its about striking that perfect balance between chasing growth and protecting what you already have.…
Honeywell International Inc. is considering walking away from its acquisition of Johnson Matthey Plc’s Catalyst Technologies business, people familiar with…
Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…
Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports…
Johnson & Johnson prepares to sell orthopedics unit for over $20 billion - Bloomberg…
Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has been planning to separate, with…
Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over…
Johnson & Johnson is investing more than $1 billion to build a new cell therapy plant in Montgomery County.…
Opportunities arise from increasing demand for energy-efficient, large-capacity, and smart refrigeration solutions, alongside the expansion of retail stores and restaurants,…
The facility is part of the company’s plans to invest $55 billion in U.S. manufacturing, research and development and technology…
Johnson & Johnson said on Wednesday it will invest more than $1 billion to build a new cell therapy facility…
• Advanced manufacturing site will utilize cutting?edge cell therapy technologies to help deliver the company’s portfolio of transformational medicines •…
Trellus Health (LON: TRLS), which has developed a digital platform to manage chronic health conditions, has secured a six-month extension…
Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial…
Johnson & Johnson ordered to pay $250,000 in talc powder lawsuit…
Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…
Market Analysis by covering: Nasdaq 100, S&P 500, Johnson & Johnson, Meta Platforms Inc. Read s Market Analysis on…
This reliable dividend payer may be just what the doctor ordered.…
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Johnson & Johnson reported impressive fourth-quarter results that beat expectations while outlining an aggressive growth strategy. And heres something investors…
RACINE, Wis., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor…
JCI delivers a strong Q1 beat with higher earnings, revenue growth across regions and margin expansion backed by lower SG&A.…
The company projects that its oncology sales will roughly double in the not-too-distant future.…
Johnson & Johnson is a picture of stability.…
Johnson & Johnson leads Zacks latest Analyst Blog as new research highlights earnings beats, growth drivers, and risks across major…
JNJs Q4 beat, Netflixs subscriber surge, and Arista Networks cloud demand highlight why these stocks headline todays top research reports.…
Morgan Stanleys price target implies that shares of Johnson & Johnson could rise another 17%.…
New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Morgan Stanley:Die Analysten von Morgan Stanley stufen die Aktie von Johnson &…